Greg Hamilton

CEO

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Gregory Hamilton, Chief Executive Officer

Gregory Hamilton has served as CEO of Epigenomics AG since July 2016.

Gregory Hamilton has over 20 years of management experience in molecular diagnostics, manufacturing and professional service industries. Prior to joining Epigenomics, Mr. Hamilton was Chief Executive Officer & Director of AltheaDx Inc., Chief Operating Officer and Chief Financial Officer of Enigma Diagnostics Inc., Vice President of Operations and Finance at Third Wave Technologies Inc. and Vice President of Operations at Hologic Inc. He has been responsible for multiple FDA-cleared products including a Human Papilloma Virus (HPV) High Risk Screening assay and the first ever cleared HPV genotyping assay. Mr. Hamilton received his MBA from the University of Chicago and his Bachelor of Science in Finance from Purdue University.